Akeso, Inc. (HKG:9926)
Hong Kong
· Delayed Price · Currency is HKD 70.95
+2.50 (3.65%)
Mar 27, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 63.68 billion as of March 27, 2025. Its market cap has increased by 59.07% in one year.
Market Cap
63.68B
Enterprise Value
63.96B
Revenue
2.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
70.95
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 63.68B, an increase of 243.41%. That is a compound annual growth rate of 28.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2025 | 63.68B | 16.89% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 211.67B |
| Hansoh Pharmaceutical Group Company | 120.47B |
| WuXi Biologics | 107.97B |
| JD Health International | 104.31B |
| Alibaba Health Information Technology | 81.53B |
| Innovent Biologics | 66.10B |
| Sino Biopharmaceutical | 63.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 59.23B |